Geneva Advisors’s ELITE PHARMACEUTICAL ELI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $75K | Buy |
401,252
+48,192
| +14% | +$9.01K | ﹤0.01% | 706 |
|
|
2017
Q1 | $52K | Buy |
353,060
+59,880
| +20% | +$8.82K | ﹤0.01% | 731 |
|
|
2016
Q4 | $45K | Hold |
293,180
| – | – | ﹤0.01% | 741 |
|
|
2016
Q3 | $52K | Hold |
293,180
| – | – | ﹤0.01% | 715 |
|
|
2016
Q2 | $95K | Hold |
293,180
| – | – | ﹤0.01% | 649 |
|
|
2016
Q1 | $91K | Hold |
293,180
| – | – | ﹤0.01% | 648 |
|
|
2015
Q4 | $120K | Buy |
293,180
+2,300
| +0.8% | +$941 | ﹤0.01% | 600 |
|
|
2015
Q3 | $67K | Hold |
290,880
| – | – | ﹤0.01% | 586 |
|
|
2015
Q2 | $58K | Hold |
290,880
| – | – | ﹤0.01% | 645 |
|
|
2015
Q1 | $71K | Hold |
290,880
| – | – | ﹤0.01% | 629 |
|
|
2014
Q4 | $66K | Hold |
290,880
| – | – | ﹤0.01% | 642 |
|
|
2014
Q3 | $93K | Buy |
290,880
+10,450
| +4% | +$3.34K | ﹤0.01% | 623 |
|
|
2014
Q2 | $119K | Hold |
280,430
| – | – | ﹤0.01% | 621 |
|
|
2014
Q1 | $115K | Buy |
280,430
+30,540
| +12% | +$12.5K | ﹤0.01% | 594 |
|
|
2013
Q4 | $30K | Hold |
249,890
| – | – | ﹤0.01% | 536 |
|
|
2013
Q3 | $31K | Buy |
249,890
+50,000
| +25% | +$6.2K | ﹤0.01% | 490 |
|
|
2013
Q2 | $14K | Buy |
+199,890
| New | +$14K | ﹤0.01% | 436 |
|